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Abstract
Background: Understanding the causes and risk factors of metabolic syndrome is important for promoting
population health. Oxidative stress has been associated with metabolic syndrome, and also obstructive sleep apnea.
These are two diseases which have common prognostic characteristics for heart disease. The aim of this study was
to examine the role of oxidative stress in the concurrent presence of metabolic syndrome and obstructive sleep
apnea in a working population.
Methods: Participants were 163 artisan bakers in Shahroud, Iran, routinely exposed to significant heat stress and
other oxidative stress indicators on a daily basis as part of their work. Using a cross-sectional design, data relevant
to determining metabolic syndrome status according to International Diabetes Federation criteria, and the presence
of obstructive sleep apnea according to the STOP-Bang score, was collected. Analyses included hierarchical binary
logistic regression to yield predictors of the two diseases.
Results: Hierarchical binary logistic regression showed that oxidative stress – alongside obesity, no regular exercise,
and smoking – was an independent predictor of metabolic syndrome, but not obstructive sleep apnea. Participants
who were obese were 28 times more likely to have metabolic syndrome (OR 28.59, 95% CI 4.91–63.02) and 44
times more likely to have obstructive sleep apnea (OR 44.48, 95% CI 4.91–403.28). Participants meeting metabolic
syndrome criteria had significantly higher levels of malondialdehyde (p < 0.05) than those who did not. No
difference in oxidative stress index levels were found according to obstructive sleep apnea status.
Conclusions: Our findings suggest that oxidative stress contributes to the onset of metabolic syndrome, and that
obstructive sleep apnea is involved in oxidative stress. Whilst obesity, exercise, and smoking remain important
targets for reducing the incidence of metabolic syndrome and obstructive sleep apnea, policies to control risks of
prolonged exposure to oxidative stress are also relevant in occupations where such environmental conditions exist.
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Background
Obstructive sleep apnea (OSA (is a sleep-related breathing
disorder. It is caused by repetitive obstruction of the upper
respiratory tract during sleep which can lead to decreased
sleep quality, hypoxia, hypercapnia, increased negative
pressure inside the chest cavity, and increased sympathetic
activity. Breathing stoppages, snoring, daytime sleepiness,
and early morning headaches are symptoms of this
disorder [1]. Epidemiological studies have shown that pa-
tients with OSA are more likely to develop cardiovascular
disease, hypertension, hyperlipidemia, insulin resistance
and atherosclerosis [2]. The repetitive cycle of upper
airway closure and opening results in a frequent hypoxia /
reoxygenation process can induce oxidative stress by an
overproduction of free radicals [3]. Oxidative stress and
OSA may share some common pathophysiological charac-
teristics such as atherosclerosis, cardiovascular disease,
and cerebral complications [4].
There are also studies suggesting that oxidative stress
plays a key role in the metabolic pathogenesis of meta-
bolic syndrome (MetS) [5]. The global epidemic of MetS,
closely linked to symptoms such as obesity, insulin
resistance, high blood pressure, impaired glucose tolerance
or diabetes, hyperinsulinemia and dyslipidemia, has signifi-
cant negative socioeconomic impacts [6]. The presence of
three of these symptoms is required for a diagnosis of MetS
[7]. Understanding the underlying causes and risk factors of
MetS can play a significance role in lifestyle, planning and
resource allocation. This is important as most researchers
believe that MetS can be considered as a prognostic sign of
cardiovascular disease as well as type 2 diabetes [8].
Normal metabolism includes the continuous produc-
tion of reactive oxygen species (ROS) and free radicals.
Redox equilibrium is vital for maintaining health. Oxida-
tive stress is seen when there is an imbalance in redox
characteristics leads to the overproduction of reactive
species or a reduction in the capability of endogenous
antioxidant systems. Both are damaging to metabolic
processes and consequently to health [9]. Reactive
oxygen species (ROS) levels are increased in obesity.
This is the major component of MetS which can be de-
creased by weight loss [10]. In addition, there is evidence
that ROS may contribute to the development of insulin
resistance, which is an important precursor of MetS [8].
Similarly, the review paper by Ando et al. [11] suggested
that ROS may also play a role in the pathogenesis of
high salt intake-induced hypertension and cardiovascular
diseases, making ROS one of the key factors in the
development of metabolic syndrome.
Hopps et al. [12] introduced assessment of oxidative
status in people with MetS as a solution to determine
the complexity of risk factors for cardiovascular diseases.
According to the review article by Roberts et al. [5],
oxidative stress is associated with many components of
metabolic syndrome, and it is the causes of metabolic
syndrome risk factors such as insulin resistance, high
blood pressure, increased lipid levels, inflammation and
endothelial dysfunction. Numerous studies have shown
that regular physical activity and dietary modifications
can prevent oxidative stress, nevertheless the molecular
mechanism by which physical activities and dietary mod-
ifications prevent oxidative stress in metabolic syndrome
is still unknown [5].
The rationale for considering MetS and OSA together
followed from reports of an association of OSA and
metabolic disorders. For example, Watz et al. [13] showed
that the risk of metabolic syndrome was 9 times higher in
people with OSA, and the treatment of OSA plays an
important role in the management of MetS [14]. To date,
no study has considered the role of oxidative stress in con-
current presence of MetS and OSA, and the relationship
of oxidative stress with these two disorders.
Bread making is an occupation which presents many
health hazards, particularly for bakers in Iran who use
traditional artisan methods. Hazards include chronic
exposure to high levels of heat from open ovens, high
levels of humidity, flour dust, shift working, and signifi-
cant manual labor: all factors that can affect oxidative
stress indicators. Of note Bolghanabadi et al. [15]
indicated high heat stress in more than 80% of bakers
working in Neyshabour. Similarly, a study in Ahvaz [16],
found most of the bakers who acted as participants to be a
risk of heat stress. Both studies made these assessments
based on wet-bulb globe temperature and made reference
to the heat stress standard ISO 7243, which has global
application [17]. Therefore, the aim of this study was to
investigate the role of oxidative stress in the incidence of
MetS and OSA using a sample of traditional artisan
bakery workers towards understanding the health risks.
Methods
Design, setting and participants
The target population of this cross-sectional study
worked in bakeries in Shahroud, Iran. The city had 95
active bakeries with 270 workers. Permission to recruit
on the basis on informed consent was provided by 74
bakery units. One hundred sixty-three male workers in
these bakeries who met the criteria for the study and
provided written consent entered the study. Inclusion
criteria were having at least 12 months of work experi-
ence and working full-time. Exclusion criteria were
illnesses such as hypertension, kidney disease and heart
failure, the use of antioxidant medication or supple-
ments, and not having routine exposure to bakery ovens.
Measures and procedure
Demographic information relating to the age, marital
status, level of education, smoking, and work experience
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of each participant was collected in person using a
standard questionnaire. (The questionnaire is available
as a Supplementary File). Each participants’ weight and
height were measured using precision instruments. Body
Mass Index (BMI) was calculated (weight in kg / height
in m2) and classified according to the World Health
Organization nutritional status: Underweight, if BMI <
18.5, Normal if BMI 18.5–29.9, Obese if BMI ≥ 30.0.
Waist circumference was measured with a non-elastic
tape (measuring accuracy ±1 mm) without imposing any
pressure on the body at the end of normal exhalation.
Participants were asked to abstain from caffeine for 30
min prior to blood pressure measurement. Blood pres-
sure was measured twice by trained individuals using a
15-min interval. The blood pressure recorded was the
average of the two readings.
Obstructive sleep apnea
The STOP-Bang questionnaire was used to identify
participants with symptoms of obstructive sleep apnea
[18]. This screening tool has been translated into Persian
and appropriate validity and reliability for OSA confirmed
[19]. STOP-Bang comprises eight yes / no questions
related to age ≥ 50 years, sex, snoring loudly, feeling sleepy
during the daytime, been observed to stop breathing
during sleep, high blood pressure, BMI ≥ 35 kg/m2, and
neck circumference ≥ 40 cm. Endorsement of three of the
eight items is indicates a high risk of OSA.
Metabolic syndrome
The International Diabetes Federation criteria [7] were
used to assess MetS (see Table 1).
Blood samples were collected after a 12-h fasting
period. Blood sugar levels were measured using a fasting
plasma glucose test (enzymatic methods: Helena Biosci-
ences). Plasma triglycerides, high-density lipoproteins
(HDL), and cholesterol levels were derived from enzym-
atic end-point measurements performed using enzyme
reagent kits and a Swiss-made automated analyzer
(Lysis). The quality of the devices was checked before
and after the tests. The repeatability of tests was con-
firmed (r = 0.995).
Oxidative stress indices
Three biochemical markers of oxidative stress were mea-
sured in serum samples. Malondialdehyde (MDA) is one
of the major end products of the oxidation of unsatur-
ated fatty acids by free radicals. It is formed by a group
of free radicals called hydroxyl radical inducing lipid per-
oxidation. Raised levels of serum MDA are indicative of
oxidative stress [20]. Nitric oxide (NO) is a major con-
tributor to normal endothelial and vascular function.
Raised NO levels indicate inflammation, and together
with other ROS, NO contributes to oxidative stress [21].
Total antioxidant capacity (TAC) assays predominantly
measure chain-breaking antioxidant activity. TAC is
lowered in oxidative stress states [22]. To assess MDA,
NO and TAC, blood samples (5 ml) were centrifuged to
separate the serum. These were stored at − 20 °C until
laboratory analysis. Oxidative stress indices in the serum
samples were assayed using kits (Hangzhou East Bio-
pharm) via a double antibody sandwich enzyme-linked
immunosorbent assay (DAS-ELISA).
Statistical analyses
SPSS statistics version 24 was used for all statistical
analyses. Alpha levels were set at 0.05 for T-Tests and
ANOVAs, and a significance level of 0.1 was used for
the hierarchical binary logistics regressions. Logistic re-
gressions were used to determine the predictive variables
of MetS and OSA.
Results
Mean age of the 163 participants was 45.4 years, 108
(66.3%) were regularly exercising and 141 (87.7%) were
non-smokers. 22 (13.50%) participants were obese
(BMI ≥ 30 kg/m2; mean 33.5 ± 2.2). According to Inter-
national Diabetes Federation criteria, 20 (12.3%) partici-
pants had MetS. According to STOP-Bang criteria, 22
(13.5%) participants had OSA.
Tables 2 and 3 show mean serum levels of MDA, NO
and TAC according to MetS status and OSA status
respectively. Participants with MetS had significantly
higher levels of MDA compared with participants with-
out MetS. There was no difference in the oxidative stress
index levels for other comparisons.
Tables 4 and 5 shows data analyses using the back-
ward log-likelihood ratio method of hierarchical binary
logistic regression. These analyses confirmed a signifi-
cant difference between some demographic variables
and the main effects of the study variables including
oxidative stress parameters.
To accurately examine the parameters affecting the
development of MetS, the role of all the variables was
Table 1 International Diabetes Federation criteria [7] for
metabolic syndrome
For someone to be classified as having MetS they must have:
Central obesity (waist circumference for this sample ≥ 94 cm), and
at least two of the four components below
Hyperglycemia Fasting glucose ≥100mg/dL or previously
diagnosed Type 2 diabetes
Plasma triglycerides TG≥ 150mg/dL or existing treatment for this
lipid abnormality
HDL cholesterol < 40mg/dl or existing treatment for this lipid
abnormality
Hypertension ≥ 130mmHg systolic or ≥ 85 mmHg diastolic
or treatment of previously diagnosed high
blood pressure
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investigated using the logistics regression model (see
Table 4). In the second stage, oxidative stress factors
were entered in addition to significant demographic
variables (< 0.1) in the univariate analysis of the first
stage. BMI, regular exercise, smoking and MDA were
identified as independent variables and strong predictors
in the final model.
The correlation between obesity (OR 28.59, 95% CI
4.91–63.02) and the development of MetS remained sig-
nificant after regression analysis (p < 0.01). In other
words, obese bakers were 28 times more likely to have
MetS (p < 0.01) compared to those of normal weight.
Regular exercise also remained significant in the last
stage, indicating that people who were not exercising
regularly were 8% more likely to develop MetS com-
pared with those who did exercise regularly (OR 1.08,
95% CI 1.06–1.21; p < 0.001). We also found that
smokers were 24.59 times more likely to develop MetS
than non-smokers (OR 24.59, 95% CI 12.26–61.7;
p < 0.001). MDA remained significant after regression
analysis so that an increase of 1 nmol/mL in serum
MDA levels increased the risk of developing MetS by
89% (OR 1.89, 95% CI 1.08–4.68; p < 0.05).
To accurately examine the parameters affecting the de-
velopment of OSA, all variables were similarly examined
using a logistics regression model (see Table 5). In the
second stage, oxidative stress factors were entered into
the model in addition to demographic variables with a
significance level of 0.1 in the first stage. BMI, regular
exercise, smoking and daily work hours were identified
as independent variables and strong predictors in the
final model.
The correlation between obesity (OR 44.48, 95% CI
4.91–403.28) and the development of OSA remained
significant after regression analysis (p < 0.01). In other
words, obese bakers were 44 times more likely to have
OSA compared with those of normal weight. Also, par-
ticipants who did not exercise regularly were 8% more
likely to develop OSA compared with those who did ex-
ercise regularly (OR 1.106, 95% CI 1.02–3.48; p < 0.01).
Smokers were 9.51 times more likely to have OSA than
non-smokers (OR 9.51, 95% CI 2.11–42.97;p < 0.01).
Daily work hours also remained significant after regres-
sion analysis in the final stage. Bakers working more
than 8 h a day were 7.42 times more likely to develop
OSA compared with those whose daily working period
was 8 h or less (OR 7.42, 95% CI 1.31–41.95; p < 0.05).
Discussion
The aim of this study was to investigate the role of oxi-
dative stress in the incidence of MetS and OSA to
understand the associated health risks. We used a sam-
ple of male bakery workers, on the basis that this was an
active occupation where exposure to an environment
conducive to oxidative stress would permit a suitable in-
vestigation. Prevalence rates of MetS and OSA among
the 163 male bakers were relatively low, which was in
keeping with a sample with relatively low obesity and
smoking levels. Of relevance, the rate of MetS in this
study (12.3%) was in keeping with the 10.88% reported
for the same city in a recent cohort study [23]. Similarly,
the prevalence of OSA was close to the recent estimate
that one in seven adults in the general population have
OSA [24].
We found BMI, regular exercise, smoking, daily work
hours and oxidative stress (as measured by malondialde-
hyde levels) had statistically significant roles in the
development of these diseases. However, BMI, regular
exercise, and smoking are common prognostic tools in
both diseases. This study replicated such findings and
for the first time looked at MetS and OSA concurrently
to examine the contribution of oxidative stress to under-
standing these diseases. Hierarchical binary logistics
regression analyses were used to allow identification of
predictor variables from our cross-sectional data [25].
We found obesity was the biggest predictor of both
MetS and OSA. The results from our study also suggest
that oxidative stress can activate pathways that play an
important role in the development of MetS. That is, oxi-
dative stress can be considered an initiator of the MetS
Table 2 Oxidative stress index levels based on MetS status
MetS Frequency (%) MDA (nmol Ml−1) NO (L−1) TAC (μmol/ L− 1)
No 143 (88) 22.21 ± 13.52 71.78 ± 46.71 2.23 ± 1.97
Yes 20 (12) 29.33 ± 19.72 62.49 ± 27.99 2.39 ± 2.85
p value – < 0.05 NS NS
Table 3 Oxidative stress index levels based on OSA status
OSA Frequency (%) MDA (nmol Ml−1) NO (L−1) TAC (μmol/ L− 1)
No 141 (87) 28.76 ± 19.19 71.72 ± 46.91 2.24 ± 1.97
Yes 22 (13) 26.54 ± 19.41 63.82 ± 28.52 2.31 ± 2.76
p value – NS NS NS
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process due to the reactions it creates in the body. How-
ever, there was no significant association of oxidative
stress and OSA.
Our findings that oxidative stress contributes to MetS
in obese men is not at odds with the literature. Specific-
ally, adipose tissue can secrete substances that play a
major role in triggering MetS inflammation [26]. Macro-
phage infiltration of adipose tissue, especially visceral fat,
is one of the characteristics of mild inflammation in
obesity and there is a positive correlation between BMI
and the amount of macrophage infiltration within adi-
pose tissue. Macrophages that are activated in adipose
tissue can secrete large amounts of pre-inflammatory
adipokines [26]. Increased activation of NF-kβv pathways
through oxidative stress and adipokine production can
contribute to increased adipokine release [27]. Moreover,
adiponectin is an important adipokine that plays a major
role in the regulation of muscle metabolism as a plasma
protein. The beneficial effects of adiponectin include its
anti-inflammatory and insulin sensitivity effects [28].
Plasma levels of adiponectin, strongly associated with
MetS, are lower in obese people than in non-obese
people [29], and people with the lowest adiponectin
levels probably have MetS [30]. Leptin is also an import-
ant adipokine and is increased in obese people [31]. Lep-
tin can increase oxidative stress and pre-inflammatory
factors [27].
The lack of an independent role for oxidative stress in
participants with symptoms of OSA was unexpected.
There are several potential reasons for this result. First,
we have to acknowledge that whilst STOP-Bang is able
to appropriately detect OSA [18, 19, 32], it is a screen
for OSA. Polysomnography is required to determine
severity of OSA. In their cross-sectional study of the role
of oxidative stress in OSA, Yamauchi et al. [33] recruited
from a sleep disorders clinic and found it was only the
group with severe OSA that had high oxidative stress
markers. In our sample of artisan bakers, the prevalence
of OSA was modest, and we cautiously suggest that the
findings may align with those of their mild OSA sample,
whilst recognizing the different methodology. Neverthe-
less, there are other studies that have also shown no
association between the incidence of OSA and increased
oxidative stress [34, 35]. A potential reason for this
evolves from the severity angle, and the thesis of Lavie
[3]. Drawing upon a range of studies she suggested that
the repetitive cycle of upper airway collapse and recov-
ery results in a frequent hypoxia / reoxygenation process
which can induce oxidative stress by an overproduction
of free radicals. Moreover, support for this involvement
comes from evidence that oxidative stress is reduced in
OSA patients following continuous positive airway treat-
ment [3]. In sum, we can understand our results do not
deny the relationship of MetS and OSA, if we recognize
that oxidative stress is involved in each disease, if in a
different way. That is, increased severity of OSA in-
creases oxidative stress, and oxidative stress is involved
in the pathogenesis of MetS.
To address the challenge of accurate measurement of
oxidative stress [22] we used three measures of oxidative
stress. These were malondialdehyde (MDA), nitric oxide
(NO), and total antioxidant capacity (TAC). We found
MDA levels were significantly raised in participants who
had MetS compared to those who did not have MetS.
Table 5 OSA predictors based on logistic regression
Variable Classification B Odds Ratio (OR)
(95% CI)
p-value
BMI (kg/m2) Normal ref ref ref
Underweight −16.33 0.81 (0.64–2.42) NS
Obese 3.79 44.48 (4.91–403.28) < 0.001
Regular exercise Yes vs No 2.24 1.106 (1.02–3.48) < 0.01
Smoker No vs Yes 2.25 9.51 (2.11–42.97) < 0.01
Daily work ≤8 vs > 8 h 2.05 7.42 (1.31–41.95) < 0.05
Table 4 MetS predictors based on logistic regression
Variable Classification B Odds Ratio (OR)
(95% CI)
p-value
BMI (kg/m2) Normal ref ref ref
Underweight 1.755 1.081 (0.65–1.73) NS
Obese 3.353 28.59 (4.91–63.02) < 0.01
Regular exercise Yes vs No 5.183 1.08 (1.06–1.211) < 0.01
Smoker No vs Yes 5.52 24.59 (12.26–61.76) < 0.001
MDA (nmol Ml−1) 0.112 1.89 (1.08–4.68) < 0.05
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There was no difference in the same participants accord-
ing to their OSA status. MDA is a commonly used
biomarker, and whilst this measure of lipid oxidation
has been criticized for being prone to artifacts, it has
also been considered to have clinical relevance in inflam-
matory diseases [9]. We did not, however, find an excess
of NO, a free radical and a marker of oxidative stress,
according to either MetS or OSA. It remains that the
measurement of NO is fraught with difficulty because of
its low concentrations in serum, and short half-life [36],
nevertheless the ELISA assay kits we used were an estab-
lished methodology.
We also took TAC measures, following the rationale
that low levels of TAC suggests oxidative stress, and be-
cause it is routinely used in oxidative stress research.
We found no difference in TAC according to MetS or
OSA status. We expected TAC levels to be decreased
relative to the significant rise in MDA levels seen in
those participants with MetS, however this was not so.
With respect to OSA, although not significant for either
biomarker, a negative relationship of MDA and TAC
was observed. This is a challenge to explain, as the
measures are from the same participants, and warrants
further investigation. That said, Young [22] argues that
despite its attraction, TAC is not a good measure of
oxidative stress because TAC assays actually measure
chain breaking antioxidant activity. In summary from
this short discussion, we report that despite the chal-
lenges of measuring oxidative stress, we are confident
the finding of role for MDA in the prediction of MetS is
useful. It remains to say, that this finding should be
replicated in due course.
As expected, we found that the absence of regular
exercise is associated with both MetS and OSA. Regular
exercise is known to improve insulin sensitivity and re-
duce the risk of MetS and obesity-related diseases [37].
There is also evidence that antioxidant enzyme activity
is increased in various tissues after aerobic and anaer-
obic exercise [38]. A regular exercise-induced adaptation
can be justified by Hormesis theory [39], and evidence of
a decrease in the production of free radicals after 12
weeks of exercise [40]. Smoking was another prognostic
tool in both diseases. Some studies have shown that
smoking can contribute to increased abdominal obesity
[41] which could be the link.
Strengths and limitations
Strengths of this study are a substantial sample of
relatively healthy bakers doing very similar work in con-
ditions which allowed us to consider the new variables
we were interested in – oxidative stress indicators – in
relation to our research questions. We were able to show
the role of MDA in the prediction of MetS despite the
prevalence of MetS in this sample being relatively low.
Similarly, we were able to suggest that oxidative stress
does not act as a precursor to OSA, but that OSA is
likely to increase oxidative stress.
An important limitation for our study was the use of a
screening tool for identification of OSA, rather than the
gold standard methodology of polysomnography. Neverthe-
less, this half survey (STOP), half personal physiologic
measures (Bang) screen was developed and validated to
support quick and inexpensive assessment of this disease
[18], as discussed above. It has been used extensively in re-
search. Moreover, a meta-analysis of 17 studies including
9206 people who completed the STOP-BANG question-
naire then underwent polysomnography concluded STOP-
BANG has excellent positive and negative predictive ability
to identify OSA [32]. Another limitation was the use of a
male only population. This was a consequence of the study
design. We recognize the need for similar studies to
replicate our findings. Such studies could be extended to
include females.
Conclusions
The present study indicates that oxidative stress is impli-
cated in the development of MetS in bakery workers. No
significant association was found between oxidative
stress and the incidence of OSA. Obesity, smoking and
exercise remain important targets for reducing the risk
of metabolic syndrome and obstructive sleep apnea and
maintaining good health. Policies to control risks of pro-
longed exposure to oxidative stress factors such as heat,
humidity, flour dust, shift work and significant manual
labor are important to ameliorating the risk of metabolic
syndrome in bakers and other occupations with these
environmental conditions.
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